Dallas IVFMarch 28, 2024

FDA 483 - Dallas IVF - March 28, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dallas IVF

Record Details

Dallas IVF, a reproductive facility, was cited for failing to adequately screen HCT/P donors and determining them eligible for donation without complete medical record reviews. Specifically, the firm did not perform required physical examinations for several semen and oocyte donors and had incomplete Zika Virus screening for an anonymous oocyte donor. These deficiencies indicate a failure to ensure donor eligibility based on proper screening and testing results.

Company: Dallas IVF
Inspection Date: March 28, 2024
Product Type: Other
Office: Division of Human and Animal Food Operations - West III
Person: Richard T. Riggie (investigator)

Open in Dashboard

ID · b2ce89ea-63cd-4c34-9716-102842567668